Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
27 Analysts have issued a Siemens Healthineers forecast:
27 Analysts have issued a Siemens Healthineers forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 23,375 23,375 |
5%
5%
|
|
| Gross Profit | 9,030 9,030 |
7%
7%
|
|
| EBITDA | 4,458 4,458 |
11%
11%
|
|
| EBIT (Operating Income) EBIT | 3,162 3,162 |
13%
13%
|
|
| Net Profit | 2,144 2,144 |
10%
10%
|
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
| Head office | Germany |
| CEO | Bernhard Montag |
| Employees | 73,100 |
| Founded | 2017 |
| Website | www.siemens-healthineers.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


